Phase I study to determine the maximum tolerated dose (MTD) and the dose limiting toxicities (DLT) of PF-00929868-01 in client-owned dogs greater than or equal to 15 kg with lymphoma
|Effective start/end date||7/15/08 → 7/15/09|
- PFIZER INC ANIMAL HEALTH GROUP
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.